Alerts
Modified Hours for Labor Day

In recognition of the upcoming Labor Day holiday, some of The University of Kansas Cancer Center’s offices will have modified hours on Monday, September 1, 2025.

Skip Navigation

Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS ? 1 Advanced Gastric and Esophageal Adenocarcinoma PARAMUNE

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
II/III

ClinicalTrials.gov Identifier:
NCT06203600

Study #:
STUDY00161146

Start Date:
Jan 21, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06203600

View Complete Trial Details & Eligibility at ClinicalTrials.gov